Guanhao Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Revenue	372.84	363.52	388.8	361.02	462.6
Other Revenue	14.91	13.97	15.38	16.27	26.38
Revenue	387.75	377.48	404.18	377.29	488.98
Revenue Growth (YoY)	2.72%	-6.60%	7.13%	-22.84%	11.91%
Cost of Revenue	90.57	78.83	88.26	159.6	125.38
Gross Profit	297.18	298.65	315.92	217.69	363.6
Selling, General & Admin	218.15	214.63	221.9	210.31	242.05
Research & Development	40.97	36.16	44.5	50.52	46.62
Other Operating Expenses	6.08	4.04	3.15	3.03	4.07
Operating Expenses	266.72	263.39	276.27	272.77	295.44
Operating Income	30.46	35.26	39.65	-55.08	68.16
Interest Expense	-4.04	-1.03	-1.78	-4.11	-7.36
Interest & Investment Income	2.56	1.27	1.5	2.22	2.19
Currency Exchange Gain (Loss)	0.17	-0.12	-3.52	-2.34	0.58
Other Non Operating Income (Expenses)	0.06	0.24	-4.11	1.11	-5.8
EBT Excluding Unusual Items	29.22	35.62	31.74	-58.2	57.77
Impairment of Goodwill	-	-	-	-214.33	-0.15
Gain (Loss) on Sale of Investments	-	-10.84	-3.64	-41.36	-4.68
Gain (Loss) on Sale of Assets	-0.01	0.03	0.92	0.03	0.33
Asset Writedown	-0.08	-4.98	-0.29	-3.61	-0.05
Other Unusual Items	-1.86	8.19	3.35	24.9	28.83
Pretax Income	27.28	28.02	32.09	-292.58	82.06
Income Tax Expense	12.49	11.41	11.02	35.06	31.32
Earnings From Continuing Operations	14.79	16.61	21.07	-327.64	50.74
Minority Interest in Earnings	9.56	10.81	9.93	19.81	22.95
Net Income	24.35	27.42	31.01	-307.82	73.69
Net Income to Common	24.35	27.42	31.01	-307.82	73.69
Net Income Growth	-11.20%	-11.58%	-	-	58.14%
Shares Outstanding (Basic)	271	274	258	265	263
Shares Outstanding (Diluted)	271	274	258	265	263
Shares Change (YoY)	-1.33%	6.11%	-2.63%	0.83%	1.66%
EPS (Basic)	0.09	0.10	0.12	-1.16	0.28
EPS (Diluted)	0.09	0.10	0.12	-1.16	0.28
EPS Growth	-10.00%	-16.67%	-	-	55.56%
Free Cash Flow	33.3	-26.65	0.23	29.81	117.68
Free Cash Flow Per Share	0.12	-0.10	0.00	0.11	0.45
Gross Margin	76.64%	79.12%	78.16%	57.70%	74.36%
Operating Margin	7.85%	9.34%	9.81%	-14.60%	13.94%
Profit Margin	6.28%	7.26%	7.67%	-81.59%	15.07%
Free Cash Flow Margin	8.59%	-7.06%	0.06%	7.90%	24.07%
EBITDA	51	55.85	61.16	-31.56	94.51
EBITDA Margin	13.15%	14.79%	15.13%	-8.37%	19.33%
D&A For EBITDA	20.54	20.59	21.51	23.52	26.35
EBIT	30.46	35.26	39.65	-55.08	68.16
EBIT Margin	7.85%	9.34%	9.81%	-14.60%	13.94%
Effective Tax Rate	45.80%	40.73%	34.33%	-	38.17%
Revenue as Reported	387.75	377.48	404.18	377.29	488.98
Advertising Expenses	10.89	10.97	12.39	9.43	15.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.